Global Artificial Intelligence in Drug Discovery Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Artificial Intelligence in Drug Discovery market size was valued at US$ 2995 million in 2025 and is forecast to a readjusted size of US$ 18430 million by 2032 with a CAGR of 30.0% during review period.
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient. Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.
The market for artificial intelligence (AI) in drug discovery is driven by the urgent need to accelerate and reduce the cost of developing new therapeutics, as traditional drug discovery is often slow, expensive, and prone to high failure rates. AI enables rapid identification of drug candidates, predictive modeling of drug-target interactions, and optimization of clinical trial design, significantly shortening development timelines. The explosion of biomedical data, including genomics, proteomics, and real-world clinical datasets, provides a rich foundation for AI algorithms to uncover novel insights. Additionally, rising investment from pharmaceutical companies, biotech firms, and venture capital in AI-driven platforms?combined with advances in deep learning, natural language processing, and generative models?is propelling adoption. Regulatory agencies? increasing openness to AI-assisted drug development workflows also supports the growth of this transformative sector.
This report is a detailed and comprehensive analysis for global Artificial Intelligence in Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Intelligence in Drug Discovery market size and forecasts, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Drug Discovery market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence in Drug Discovery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence in Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Artificial Intelligence in Drug Discovery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Intelligence in Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence in Drug Discovery, with revenue, gross margin, and global market share of Artificial Intelligence in Drug Discovery from 2021 to 2026.
Chapter 3, the Artificial Intelligence in Drug Discovery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence in Drug Discovery market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence in Drug Discovery.
Chapter 13, to describe Artificial Intelligence in Drug Discovery research findings and conclusion.
Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient. Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.
The market for artificial intelligence (AI) in drug discovery is driven by the urgent need to accelerate and reduce the cost of developing new therapeutics, as traditional drug discovery is often slow, expensive, and prone to high failure rates. AI enables rapid identification of drug candidates, predictive modeling of drug-target interactions, and optimization of clinical trial design, significantly shortening development timelines. The explosion of biomedical data, including genomics, proteomics, and real-world clinical datasets, provides a rich foundation for AI algorithms to uncover novel insights. Additionally, rising investment from pharmaceutical companies, biotech firms, and venture capital in AI-driven platforms?combined with advances in deep learning, natural language processing, and generative models?is propelling adoption. Regulatory agencies? increasing openness to AI-assisted drug development workflows also supports the growth of this transformative sector.
This report is a detailed and comprehensive analysis for global Artificial Intelligence in Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Artificial Intelligence in Drug Discovery market size and forecasts, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Drug Discovery market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Intelligence in Drug Discovery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Intelligence in Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Artificial Intelligence in Drug Discovery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Hardware
- Software
- Service
- Early Drug Discovery
- Preclinical Phase
- Clinical Phase
- Regulatory Approval
- IBM
- Exscientia
- Google(Alphabet)
- Microsoft
- Atomwise
- Schrodinger
- Aitia
- Insilico Medicine
- NVIDIA
- XtalPi
- BPGbio
- Owkin
- CytoReason
- Deep Genomics
- Cloud Pharmaceuticals
- BenevolentAI
- Cyclica
- Verge Genomics
- Valo Health
- Envisagenics
- Euretos
- BioAge Labs
- Iktos
- BioSymetrics
- Evaxion Biotech
- Aria Pharmaceuticals, Inc
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Artificial Intelligence in Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Artificial Intelligence in Drug Discovery, with revenue, gross margin, and global market share of Artificial Intelligence in Drug Discovery from 2021 to 2026.
Chapter 3, the Artificial Intelligence in Drug Discovery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence in Drug Discovery market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence in Drug Discovery.
Chapter 13, to describe Artificial Intelligence in Drug Discovery research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence in Drug Discovery by Type
1.3.1 Overview: Global Artificial Intelligence in Drug Discovery Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type in 2025
1.3.3 Hardware
1.3.4 Software
1.3.5 Service
1.4 Global Artificial Intelligence in Drug Discovery Market by Application
1.4.1 Overview: Global Artificial Intelligence in Drug Discovery Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Early Drug Discovery
1.4.3 Preclinical Phase
1.4.4 Clinical Phase
1.4.5 Regulatory Approval
1.5 Global Artificial Intelligence in Drug Discovery Market Size & Forecast
1.6 Global Artificial Intelligence in Drug Discovery Market Size and Forecast by Region
1.6.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Artificial Intelligence in Drug Discovery Market Size by Region, (2021-2032)
1.6.3 North America Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.4 Europe Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.6 South America Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 IBM
2.1.1 IBM Details
2.1.2 IBM Major Business
2.1.3 IBM Artificial Intelligence in Drug Discovery Product and Solutions
2.1.4 IBM Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 IBM Recent Developments and Future Plans
2.2 Exscientia
2.2.1 Exscientia Details
2.2.2 Exscientia Major Business
2.2.3 Exscientia Artificial Intelligence in Drug Discovery Product and Solutions
2.2.4 Exscientia Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Exscientia Recent Developments and Future Plans
2.3 Google(Alphabet)
2.3.1 Google(Alphabet) Details
2.3.2 Google(Alphabet) Major Business
2.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Product and Solutions
2.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Google(Alphabet) Recent Developments and Future Plans
2.4 Microsoft
2.4.1 Microsoft Details
2.4.2 Microsoft Major Business
2.4.3 Microsoft Artificial Intelligence in Drug Discovery Product and Solutions
2.4.4 Microsoft Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Microsoft Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise Artificial Intelligence in Drug Discovery Product and Solutions
2.5.4 Atomwise Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Schrodinger
2.6.1 Schrodinger Details
2.6.2 Schrodinger Major Business
2.6.3 Schrodinger Artificial Intelligence in Drug Discovery Product and Solutions
2.6.4 Schrodinger Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Schrodinger Recent Developments and Future Plans
2.7 Aitia
2.7.1 Aitia Details
2.7.2 Aitia Major Business
2.7.3 Aitia Artificial Intelligence in Drug Discovery Product and Solutions
2.7.4 Aitia Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Aitia Recent Developments and Future Plans
2.8 Insilico Medicine
2.8.1 Insilico Medicine Details
2.8.2 Insilico Medicine Major Business
2.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Product and Solutions
2.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Insilico Medicine Recent Developments and Future Plans
2.9 NVIDIA
2.9.1 NVIDIA Details
2.9.2 NVIDIA Major Business
2.9.3 NVIDIA Artificial Intelligence in Drug Discovery Product and Solutions
2.9.4 NVIDIA Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 NVIDIA Recent Developments and Future Plans
2.10 XtalPi
2.10.1 XtalPi Details
2.10.2 XtalPi Major Business
2.10.3 XtalPi Artificial Intelligence in Drug Discovery Product and Solutions
2.10.4 XtalPi Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 XtalPi Recent Developments and Future Plans
2.11 BPGbio
2.11.1 BPGbio Details
2.11.2 BPGbio Major Business
2.11.3 BPGbio Artificial Intelligence in Drug Discovery Product and Solutions
2.11.4 BPGbio Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 BPGbio Recent Developments and Future Plans
2.12 Owkin
2.12.1 Owkin Details
2.12.2 Owkin Major Business
2.12.3 Owkin Artificial Intelligence in Drug Discovery Product and Solutions
2.12.4 Owkin Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Owkin Recent Developments and Future Plans
2.13 CytoReason
2.13.1 CytoReason Details
2.13.2 CytoReason Major Business
2.13.3 CytoReason Artificial Intelligence in Drug Discovery Product and Solutions
2.13.4 CytoReason Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 CytoReason Recent Developments and Future Plans
2.14 Deep Genomics
2.14.1 Deep Genomics Details
2.14.2 Deep Genomics Major Business
2.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Product and Solutions
2.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Deep Genomics Recent Developments and Future Plans
2.15 Cloud Pharmaceuticals
2.15.1 Cloud Pharmaceuticals Details
2.15.2 Cloud Pharmaceuticals Major Business
2.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product and Solutions
2.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.16 BenevolentAI
2.16.1 BenevolentAI Details
2.16.2 BenevolentAI Major Business
2.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Product and Solutions
2.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 BenevolentAI Recent Developments and Future Plans
2.17 Cyclica
2.17.1 Cyclica Details
2.17.2 Cyclica Major Business
2.17.3 Cyclica Artificial Intelligence in Drug Discovery Product and Solutions
2.17.4 Cyclica Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Cyclica Recent Developments and Future Plans
2.18 Verge Genomics
2.18.1 Verge Genomics Details
2.18.2 Verge Genomics Major Business
2.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Product and Solutions
2.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Verge Genomics Recent Developments and Future Plans
2.19 Valo Health
2.19.1 Valo Health Details
2.19.2 Valo Health Major Business
2.19.3 Valo Health Artificial Intelligence in Drug Discovery Product and Solutions
2.19.4 Valo Health Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Valo Health Recent Developments and Future Plans
2.20 Envisagenics
2.20.1 Envisagenics Details
2.20.2 Envisagenics Major Business
2.20.3 Envisagenics Artificial Intelligence in Drug Discovery Product and Solutions
2.20.4 Envisagenics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Envisagenics Recent Developments and Future Plans
2.21 Euretos
2.21.1 Euretos Details
2.21.2 Euretos Major Business
2.21.3 Euretos Artificial Intelligence in Drug Discovery Product and Solutions
2.21.4 Euretos Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Euretos Recent Developments and Future Plans
2.22 BioAge Labs
2.22.1 BioAge Labs Details
2.22.2 BioAge Labs Major Business
2.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Product and Solutions
2.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 BioAge Labs Recent Developments and Future Plans
2.23 Iktos
2.23.1 Iktos Details
2.23.2 Iktos Major Business
2.23.3 Iktos Artificial Intelligence in Drug Discovery Product and Solutions
2.23.4 Iktos Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Iktos Recent Developments and Future Plans
2.24 BioSymetrics
2.24.1 BioSymetrics Details
2.24.2 BioSymetrics Major Business
2.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Product and Solutions
2.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 BioSymetrics Recent Developments and Future Plans
2.25 Evaxion Biotech
2.25.1 Evaxion Biotech Details
2.25.2 Evaxion Biotech Major Business
2.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Product and Solutions
2.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Evaxion Biotech Recent Developments and Future Plans
2.26 Aria Pharmaceuticals, Inc
2.26.1 Aria Pharmaceuticals, Inc Details
2.26.2 Aria Pharmaceuticals, Inc Major Business
2.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product and Solutions
2.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Aria Pharmaceuticals, Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence in Drug Discovery Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Artificial Intelligence in Drug Discovery by Company Revenue
3.2.2 Top 3 Artificial Intelligence in Drug Discovery Players Market Share in 2025
3.2.3 Top 6 Artificial Intelligence in Drug Discovery Players Market Share in 2025
3.3 Artificial Intelligence in Drug Discovery Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence in Drug Discovery Market: Region Footprint
3.3.2 Artificial Intelligence in Drug Discovery Market: Company Product Type Footprint
3.3.3 Artificial Intelligence in Drug Discovery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence in Drug Discovery Consumption Value and Market Share by Type (2021-2026)
4.2 Global Artificial Intelligence in Drug Discovery Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2026)
5.2 Global Artificial Intelligence in Drug Discovery Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
6.2 North America Artificial Intelligence in Drug Discovery Market Size by Application (2021-2032)
6.3 North America Artificial Intelligence in Drug Discovery Market Size by Country
6.3.1 North America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
6.3.2 United States Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
6.3.3 Canada Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
6.3.4 Mexico Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
7.2 Europe Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country
7.3.1 Europe Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
7.3.2 Germany Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.3 France Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.5 Russia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.6 Italy Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Region (2021-2032)
8.3.2 China Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.3 Japan Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.4 South Korea Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.5 India Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.7 Australia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
9.2 South America Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
9.3 South America Artificial Intelligence in Drug Discovery Market Size by Country
9.3.1 South America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
9.3.2 Brazil Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
9.3.3 Argentina Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
10.3.2 Turkey Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
10.3.4 UAE Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Artificial Intelligence in Drug Discovery Market Drivers
11.2 Artificial Intelligence in Drug Discovery Market Restraints
11.3 Artificial Intelligence in Drug Discovery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence in Drug Discovery Industry Chain
12.2 Artificial Intelligence in Drug Discovery Upstream Analysis
12.3 Artificial Intelligence in Drug Discovery Midstream Analysis
12.4 Artificial Intelligence in Drug Discovery Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence in Drug Discovery by Type
1.3.1 Overview: Global Artificial Intelligence in Drug Discovery Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type in 2025
1.3.3 Hardware
1.3.4 Software
1.3.5 Service
1.4 Global Artificial Intelligence in Drug Discovery Market by Application
1.4.1 Overview: Global Artificial Intelligence in Drug Discovery Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Early Drug Discovery
1.4.3 Preclinical Phase
1.4.4 Clinical Phase
1.4.5 Regulatory Approval
1.5 Global Artificial Intelligence in Drug Discovery Market Size & Forecast
1.6 Global Artificial Intelligence in Drug Discovery Market Size and Forecast by Region
1.6.1 Global Artificial Intelligence in Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Artificial Intelligence in Drug Discovery Market Size by Region, (2021-2032)
1.6.3 North America Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.4 Europe Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.6 South America Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 IBM
2.1.1 IBM Details
2.1.2 IBM Major Business
2.1.3 IBM Artificial Intelligence in Drug Discovery Product and Solutions
2.1.4 IBM Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 IBM Recent Developments and Future Plans
2.2 Exscientia
2.2.1 Exscientia Details
2.2.2 Exscientia Major Business
2.2.3 Exscientia Artificial Intelligence in Drug Discovery Product and Solutions
2.2.4 Exscientia Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Exscientia Recent Developments and Future Plans
2.3 Google(Alphabet)
2.3.1 Google(Alphabet) Details
2.3.2 Google(Alphabet) Major Business
2.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Product and Solutions
2.3.4 Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Google(Alphabet) Recent Developments and Future Plans
2.4 Microsoft
2.4.1 Microsoft Details
2.4.2 Microsoft Major Business
2.4.3 Microsoft Artificial Intelligence in Drug Discovery Product and Solutions
2.4.4 Microsoft Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Microsoft Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise Artificial Intelligence in Drug Discovery Product and Solutions
2.5.4 Atomwise Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Schrodinger
2.6.1 Schrodinger Details
2.6.2 Schrodinger Major Business
2.6.3 Schrodinger Artificial Intelligence in Drug Discovery Product and Solutions
2.6.4 Schrodinger Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Schrodinger Recent Developments and Future Plans
2.7 Aitia
2.7.1 Aitia Details
2.7.2 Aitia Major Business
2.7.3 Aitia Artificial Intelligence in Drug Discovery Product and Solutions
2.7.4 Aitia Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Aitia Recent Developments and Future Plans
2.8 Insilico Medicine
2.8.1 Insilico Medicine Details
2.8.2 Insilico Medicine Major Business
2.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Product and Solutions
2.8.4 Insilico Medicine Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Insilico Medicine Recent Developments and Future Plans
2.9 NVIDIA
2.9.1 NVIDIA Details
2.9.2 NVIDIA Major Business
2.9.3 NVIDIA Artificial Intelligence in Drug Discovery Product and Solutions
2.9.4 NVIDIA Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 NVIDIA Recent Developments and Future Plans
2.10 XtalPi
2.10.1 XtalPi Details
2.10.2 XtalPi Major Business
2.10.3 XtalPi Artificial Intelligence in Drug Discovery Product and Solutions
2.10.4 XtalPi Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 XtalPi Recent Developments and Future Plans
2.11 BPGbio
2.11.1 BPGbio Details
2.11.2 BPGbio Major Business
2.11.3 BPGbio Artificial Intelligence in Drug Discovery Product and Solutions
2.11.4 BPGbio Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 BPGbio Recent Developments and Future Plans
2.12 Owkin
2.12.1 Owkin Details
2.12.2 Owkin Major Business
2.12.3 Owkin Artificial Intelligence in Drug Discovery Product and Solutions
2.12.4 Owkin Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Owkin Recent Developments and Future Plans
2.13 CytoReason
2.13.1 CytoReason Details
2.13.2 CytoReason Major Business
2.13.3 CytoReason Artificial Intelligence in Drug Discovery Product and Solutions
2.13.4 CytoReason Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 CytoReason Recent Developments and Future Plans
2.14 Deep Genomics
2.14.1 Deep Genomics Details
2.14.2 Deep Genomics Major Business
2.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Product and Solutions
2.14.4 Deep Genomics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Deep Genomics Recent Developments and Future Plans
2.15 Cloud Pharmaceuticals
2.15.1 Cloud Pharmaceuticals Details
2.15.2 Cloud Pharmaceuticals Major Business
2.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product and Solutions
2.15.4 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.16 BenevolentAI
2.16.1 BenevolentAI Details
2.16.2 BenevolentAI Major Business
2.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Product and Solutions
2.16.4 BenevolentAI Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 BenevolentAI Recent Developments and Future Plans
2.17 Cyclica
2.17.1 Cyclica Details
2.17.2 Cyclica Major Business
2.17.3 Cyclica Artificial Intelligence in Drug Discovery Product and Solutions
2.17.4 Cyclica Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Cyclica Recent Developments and Future Plans
2.18 Verge Genomics
2.18.1 Verge Genomics Details
2.18.2 Verge Genomics Major Business
2.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Product and Solutions
2.18.4 Verge Genomics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Verge Genomics Recent Developments and Future Plans
2.19 Valo Health
2.19.1 Valo Health Details
2.19.2 Valo Health Major Business
2.19.3 Valo Health Artificial Intelligence in Drug Discovery Product and Solutions
2.19.4 Valo Health Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Valo Health Recent Developments and Future Plans
2.20 Envisagenics
2.20.1 Envisagenics Details
2.20.2 Envisagenics Major Business
2.20.3 Envisagenics Artificial Intelligence in Drug Discovery Product and Solutions
2.20.4 Envisagenics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Envisagenics Recent Developments and Future Plans
2.21 Euretos
2.21.1 Euretos Details
2.21.2 Euretos Major Business
2.21.3 Euretos Artificial Intelligence in Drug Discovery Product and Solutions
2.21.4 Euretos Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Euretos Recent Developments and Future Plans
2.22 BioAge Labs
2.22.1 BioAge Labs Details
2.22.2 BioAge Labs Major Business
2.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Product and Solutions
2.22.4 BioAge Labs Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 BioAge Labs Recent Developments and Future Plans
2.23 Iktos
2.23.1 Iktos Details
2.23.2 Iktos Major Business
2.23.3 Iktos Artificial Intelligence in Drug Discovery Product and Solutions
2.23.4 Iktos Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Iktos Recent Developments and Future Plans
2.24 BioSymetrics
2.24.1 BioSymetrics Details
2.24.2 BioSymetrics Major Business
2.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Product and Solutions
2.24.4 BioSymetrics Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 BioSymetrics Recent Developments and Future Plans
2.25 Evaxion Biotech
2.25.1 Evaxion Biotech Details
2.25.2 Evaxion Biotech Major Business
2.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Product and Solutions
2.25.4 Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Evaxion Biotech Recent Developments and Future Plans
2.26 Aria Pharmaceuticals, Inc
2.26.1 Aria Pharmaceuticals, Inc Details
2.26.2 Aria Pharmaceuticals, Inc Major Business
2.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product and Solutions
2.26.4 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Aria Pharmaceuticals, Inc Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence in Drug Discovery Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Artificial Intelligence in Drug Discovery by Company Revenue
3.2.2 Top 3 Artificial Intelligence in Drug Discovery Players Market Share in 2025
3.2.3 Top 6 Artificial Intelligence in Drug Discovery Players Market Share in 2025
3.3 Artificial Intelligence in Drug Discovery Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence in Drug Discovery Market: Region Footprint
3.3.2 Artificial Intelligence in Drug Discovery Market: Company Product Type Footprint
3.3.3 Artificial Intelligence in Drug Discovery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence in Drug Discovery Consumption Value and Market Share by Type (2021-2026)
4.2 Global Artificial Intelligence in Drug Discovery Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2026)
5.2 Global Artificial Intelligence in Drug Discovery Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
6.2 North America Artificial Intelligence in Drug Discovery Market Size by Application (2021-2032)
6.3 North America Artificial Intelligence in Drug Discovery Market Size by Country
6.3.1 North America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
6.3.2 United States Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
6.3.3 Canada Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
6.3.4 Mexico Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
7.2 Europe Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country
7.3.1 Europe Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
7.3.2 Germany Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.3 France Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.5 Russia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
7.3.6 Italy Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Artificial Intelligence in Drug Discovery Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Region (2021-2032)
8.3.2 China Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.3 Japan Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.4 South Korea Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.5 India Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
8.3.7 Australia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
9.2 South America Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
9.3 South America Artificial Intelligence in Drug Discovery Market Size by Country
9.3.1 South America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
9.3.2 Brazil Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
9.3.3 Argentina Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Artificial Intelligence in Drug Discovery Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2032)
10.3.2 Turkey Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
10.3.4 UAE Artificial Intelligence in Drug Discovery Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Artificial Intelligence in Drug Discovery Market Drivers
11.2 Artificial Intelligence in Drug Discovery Market Restraints
11.3 Artificial Intelligence in Drug Discovery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence in Drug Discovery Industry Chain
12.2 Artificial Intelligence in Drug Discovery Upstream Analysis
12.3 Artificial Intelligence in Drug Discovery Midstream Analysis
12.4 Artificial Intelligence in Drug Discovery Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF FIGURES
Table 1. Global Artificial Intelligence in Drug Discovery Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Intelligence in Drug Discovery Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Intelligence in Drug Discovery Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Artificial Intelligence in Drug Discovery Consumption Value by Region (2027-2032) & (USD Million)
Table 5. IBM Company Information, Head Office, and Major Competitors
Table 6. IBM Major Business
Table 7. IBM Artificial Intelligence in Drug Discovery Product and Solutions
Table 8. IBM Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. IBM Recent Developments and Future Plans
Table 10. Exscientia Company Information, Head Office, and Major Competitors
Table 11. Exscientia Major Business
Table 12. Exscientia Artificial Intelligence in Drug Discovery Product and Solutions
Table 13. Exscientia Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Exscientia Recent Developments and Future Plans
Table 15. Google(Alphabet) Company Information, Head Office, and Major Competitors
Table 16. Google(Alphabet) Major Business
Table 17. Google(Alphabet) Artificial Intelligence in Drug Discovery Product and Solutions
Table 18. Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Microsoft Company Information, Head Office, and Major Competitors
Table 20. Microsoft Major Business
Table 21. Microsoft Artificial Intelligence in Drug Discovery Product and Solutions
Table 22. Microsoft Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Microsoft Recent Developments and Future Plans
Table 24. Atomwise Company Information, Head Office, and Major Competitors
Table 25. Atomwise Major Business
Table 26. Atomwise Artificial Intelligence in Drug Discovery Product and Solutions
Table 27. Atomwise Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Atomwise Recent Developments and Future Plans
Table 29. Schrodinger Company Information, Head Office, and Major Competitors
Table 30. Schrodinger Major Business
Table 31. Schrodinger Artificial Intelligence in Drug Discovery Product and Solutions
Table 32. Schrodinger Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Schrodinger Recent Developments and Future Plans
Table 34. Aitia Company Information, Head Office, and Major Competitors
Table 35. Aitia Major Business
Table 36. Aitia Artificial Intelligence in Drug Discovery Product and Solutions
Table 37. Aitia Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Aitia Recent Developments and Future Plans
Table 39. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 40. Insilico Medicine Major Business
Table 41. Insilico Medicine Artificial Intelligence in Drug Discovery Product and Solutions
Table 42. Insilico Medicine Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Insilico Medicine Recent Developments and Future Plans
Table 44. NVIDIA Company Information, Head Office, and Major Competitors
Table 45. NVIDIA Major Business
Table 46. NVIDIA Artificial Intelligence in Drug Discovery Product and Solutions
Table 47. NVIDIA Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. NVIDIA Recent Developments and Future Plans
Table 49. XtalPi Company Information, Head Office, and Major Competitors
Table 50. XtalPi Major Business
Table 51. XtalPi Artificial Intelligence in Drug Discovery Product and Solutions
Table 52. XtalPi Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. XtalPi Recent Developments and Future Plans
Table 54. BPGbio Company Information, Head Office, and Major Competitors
Table 55. BPGbio Major Business
Table 56. BPGbio Artificial Intelligence in Drug Discovery Product and Solutions
Table 57. BPGbio Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. BPGbio Recent Developments and Future Plans
Table 59. Owkin Company Information, Head Office, and Major Competitors
Table 60. Owkin Major Business
Table 61. Owkin Artificial Intelligence in Drug Discovery Product and Solutions
Table 62. Owkin Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Owkin Recent Developments and Future Plans
Table 64. CytoReason Company Information, Head Office, and Major Competitors
Table 65. CytoReason Major Business
Table 66. CytoReason Artificial Intelligence in Drug Discovery Product and Solutions
Table 67. CytoReason Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. CytoReason Recent Developments and Future Plans
Table 69. Deep Genomics Company Information, Head Office, and Major Competitors
Table 70. Deep Genomics Major Business
Table 71. Deep Genomics Artificial Intelligence in Drug Discovery Product and Solutions
Table 72. Deep Genomics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Deep Genomics Recent Developments and Future Plans
Table 74. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 75. Cloud Pharmaceuticals Major Business
Table 76. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product and Solutions
Table 77. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 79. BenevolentAI Company Information, Head Office, and Major Competitors
Table 80. BenevolentAI Major Business
Table 81. BenevolentAI Artificial Intelligence in Drug Discovery Product and Solutions
Table 82. BenevolentAI Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. BenevolentAI Recent Developments and Future Plans
Table 84. Cyclica Company Information, Head Office, and Major Competitors
Table 85. Cyclica Major Business
Table 86. Cyclica Artificial Intelligence in Drug Discovery Product and Solutions
Table 87. Cyclica Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. Cyclica Recent Developments and Future Plans
Table 89. Verge Genomics Company Information, Head Office, and Major Competitors
Table 90. Verge Genomics Major Business
Table 91. Verge Genomics Artificial Intelligence in Drug Discovery Product and Solutions
Table 92. Verge Genomics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. Verge Genomics Recent Developments and Future Plans
Table 94. Valo Health Company Information, Head Office, and Major Competitors
Table 95. Valo Health Major Business
Table 96. Valo Health Artificial Intelligence in Drug Discovery Product and Solutions
Table 97. Valo Health Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Valo Health Recent Developments and Future Plans
Table 99. Envisagenics Company Information, Head Office, and Major Competitors
Table 100. Envisagenics Major Business
Table 101. Envisagenics Artificial Intelligence in Drug Discovery Product and Solutions
Table 102. Envisagenics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Envisagenics Recent Developments and Future Plans
Table 104. Euretos Company Information, Head Office, and Major Competitors
Table 105. Euretos Major Business
Table 106. Euretos Artificial Intelligence in Drug Discovery Product and Solutions
Table 107. Euretos Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Euretos Recent Developments and Future Plans
Table 109. BioAge Labs Company Information, Head Office, and Major Competitors
Table 110. BioAge Labs Major Business
Table 111. BioAge Labs Artificial Intelligence in Drug Discovery Product and Solutions
Table 112. BioAge Labs Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. BioAge Labs Recent Developments and Future Plans
Table 114. Iktos Company Information, Head Office, and Major Competitors
Table 115. Iktos Major Business
Table 116. Iktos Artificial Intelligence in Drug Discovery Product and Solutions
Table 117. Iktos Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 118. Iktos Recent Developments and Future Plans
Table 119. BioSymetrics Company Information, Head Office, and Major Competitors
Table 120. BioSymetrics Major Business
Table 121. BioSymetrics Artificial Intelligence in Drug Discovery Product and Solutions
Table 122. BioSymetrics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 123. BioSymetrics Recent Developments and Future Plans
Table 124. Evaxion Biotech Company Information, Head Office, and Major Competitors
Table 125. Evaxion Biotech Major Business
Table 126. Evaxion Biotech Artificial Intelligence in Drug Discovery Product and Solutions
Table 127. Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Evaxion Biotech Recent Developments and Future Plans
Table 129. Aria Pharmaceuticals, Inc Company Information, Head Office, and Major Competitors
Table 130. Aria Pharmaceuticals, Inc Major Business
Table 131. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product and Solutions
Table 132. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Aria Pharmaceuticals, Inc Recent Developments and Future Plans
Table 134. Global Artificial Intelligence in Drug Discovery Revenue (USD Million) by Players (2021-2026)
Table 135. Global Artificial Intelligence in Drug Discovery Revenue Share by Players (2021-2026)
Table 136. Breakdown of Artificial Intelligence in Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3)
Table 137. Market Position of Players in Artificial Intelligence in Drug Discovery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 138. Head Office of Key Artificial Intelligence in Drug Discovery Players
Table 139. Artificial Intelligence in Drug Discovery Market: Company Product Type Footprint
Table 140. Artificial Intelligence in Drug Discovery Market: Company Product Application Footprint
Table 141. Artificial Intelligence in Drug Discovery New Market Entrants and Barriers to Market Entry
Table 142. Artificial Intelligence in Drug Discovery Mergers, Acquisition, Agreements, and Collaborations
Table 143. Global Artificial Intelligence in Drug Discovery Consumption Value (USD Million) by Type (2021-2026)
Table 144. Global Artificial Intelligence in Drug Discovery Consumption Value Share by Type (2021-2026)
Table 145. Global Artificial Intelligence in Drug Discovery Consumption Value Forecast by Type (2027-2032)
Table 146. Global Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026)
Table 147. Global Artificial Intelligence in Drug Discovery Consumption Value Forecast by Application (2027-2032)
Table 148. North America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 149. North America Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 150. North America Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 151. North America Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 152. North America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 153. North America Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 154. Europe Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 155. Europe Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 156. Europe Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 157. Europe Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 158. Europe Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 159. Europe Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 160. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 161. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 162. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 163. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 164. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Region (2021-2026) & (USD Million)
Table 165. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Region (2027-2032) & (USD Million)
Table 166. South America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 167. South America Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 168. South America Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 169. South America Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 170. South America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 171. South America Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 172. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 173. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 174. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 175. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 176. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 177. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 178. Global Key Players of Artificial Intelligence in Drug Discovery Upstream (Raw Materials)
Table 179. Global Artificial Intelligence in Drug Discovery Typical Customers
LIST OF FIGURES
Figure 1. Artificial Intelligence in Drug Discovery Picture
Figure 2. Global Artificial Intelligence in Drug Discovery Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type in 2025
Figure 4. Hardware
Figure 5. Software
Figure 6. Service
Figure 7. Global Artificial Intelligence in Drug Discovery Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application in 2025
Figure 9. Early Drug Discovery Picture
Figure 10. Preclinical Phase Picture
Figure 11. Clinical Phase Picture
Figure 12. Regulatory Approval Picture
Figure 13. Global Artificial Intelligence in Drug Discovery Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Artificial Intelligence in Drug Discovery Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Market Artificial Intelligence in Drug Discovery Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 16. Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Region (2021-2032)
Figure 17. Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Region in 2025
Figure 18. North America Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 20. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 21. South America Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 22. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Artificial Intelligence in Drug Discovery Revenue Share by Players in 2025
Figure 25. Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 26. Market Share of Artificial Intelligence in Drug Discovery by Player Revenue in 2025
Figure 27. Top 3 Artificial Intelligence in Drug Discovery Players Market Share in 2025
Figure 28. Top 6 Artificial Intelligence in Drug Discovery Players Market Share in 2025
Figure 29. Global Artificial Intelligence in Drug Discovery Consumption Value Share by Type (2021-2026)
Figure 30. Global Artificial Intelligence in Drug Discovery Market Share Forecast by Type (2027-2032)
Figure 31. Global Artificial Intelligence in Drug Discovery Consumption Value Share by Application (2021-2026)
Figure 32. Global Artificial Intelligence in Drug Discovery Market Share Forecast by Application (2027-2032)
Figure 33. North America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 34. North America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 35. North America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 40. Europe Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 41. Europe Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 42. Germany Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 43. France Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 44. United Kingdom Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 45. Russia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 46. Italy Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 48. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 49. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value Market Share by Region (2021-2032)
Figure 50. China Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 51. Japan Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 52. South Korea Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 53. India Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 54. Southeast Asia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 55. Australia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 56. South America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 57. South America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 58. South America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 59. Brazil Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 60. Argentina Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 61. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 62. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 63. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 64. Turkey Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 65. Saudi Arabia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 66. UAE Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 67. Artificial Intelligence in Drug Discovery Market Drivers
Figure 68. Artificial Intelligence in Drug Discovery Market Restraints
Figure 69. Artificial Intelligence in Drug Discovery Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Artificial Intelligence in Drug Discovery Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Table 1. Global Artificial Intelligence in Drug Discovery Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Intelligence in Drug Discovery Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Intelligence in Drug Discovery Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Artificial Intelligence in Drug Discovery Consumption Value by Region (2027-2032) & (USD Million)
Table 5. IBM Company Information, Head Office, and Major Competitors
Table 6. IBM Major Business
Table 7. IBM Artificial Intelligence in Drug Discovery Product and Solutions
Table 8. IBM Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. IBM Recent Developments and Future Plans
Table 10. Exscientia Company Information, Head Office, and Major Competitors
Table 11. Exscientia Major Business
Table 12. Exscientia Artificial Intelligence in Drug Discovery Product and Solutions
Table 13. Exscientia Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Exscientia Recent Developments and Future Plans
Table 15. Google(Alphabet) Company Information, Head Office, and Major Competitors
Table 16. Google(Alphabet) Major Business
Table 17. Google(Alphabet) Artificial Intelligence in Drug Discovery Product and Solutions
Table 18. Google(Alphabet) Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Microsoft Company Information, Head Office, and Major Competitors
Table 20. Microsoft Major Business
Table 21. Microsoft Artificial Intelligence in Drug Discovery Product and Solutions
Table 22. Microsoft Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Microsoft Recent Developments and Future Plans
Table 24. Atomwise Company Information, Head Office, and Major Competitors
Table 25. Atomwise Major Business
Table 26. Atomwise Artificial Intelligence in Drug Discovery Product and Solutions
Table 27. Atomwise Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Atomwise Recent Developments and Future Plans
Table 29. Schrodinger Company Information, Head Office, and Major Competitors
Table 30. Schrodinger Major Business
Table 31. Schrodinger Artificial Intelligence in Drug Discovery Product and Solutions
Table 32. Schrodinger Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Schrodinger Recent Developments and Future Plans
Table 34. Aitia Company Information, Head Office, and Major Competitors
Table 35. Aitia Major Business
Table 36. Aitia Artificial Intelligence in Drug Discovery Product and Solutions
Table 37. Aitia Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Aitia Recent Developments and Future Plans
Table 39. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 40. Insilico Medicine Major Business
Table 41. Insilico Medicine Artificial Intelligence in Drug Discovery Product and Solutions
Table 42. Insilico Medicine Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Insilico Medicine Recent Developments and Future Plans
Table 44. NVIDIA Company Information, Head Office, and Major Competitors
Table 45. NVIDIA Major Business
Table 46. NVIDIA Artificial Intelligence in Drug Discovery Product and Solutions
Table 47. NVIDIA Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. NVIDIA Recent Developments and Future Plans
Table 49. XtalPi Company Information, Head Office, and Major Competitors
Table 50. XtalPi Major Business
Table 51. XtalPi Artificial Intelligence in Drug Discovery Product and Solutions
Table 52. XtalPi Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. XtalPi Recent Developments and Future Plans
Table 54. BPGbio Company Information, Head Office, and Major Competitors
Table 55. BPGbio Major Business
Table 56. BPGbio Artificial Intelligence in Drug Discovery Product and Solutions
Table 57. BPGbio Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. BPGbio Recent Developments and Future Plans
Table 59. Owkin Company Information, Head Office, and Major Competitors
Table 60. Owkin Major Business
Table 61. Owkin Artificial Intelligence in Drug Discovery Product and Solutions
Table 62. Owkin Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Owkin Recent Developments and Future Plans
Table 64. CytoReason Company Information, Head Office, and Major Competitors
Table 65. CytoReason Major Business
Table 66. CytoReason Artificial Intelligence in Drug Discovery Product and Solutions
Table 67. CytoReason Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. CytoReason Recent Developments and Future Plans
Table 69. Deep Genomics Company Information, Head Office, and Major Competitors
Table 70. Deep Genomics Major Business
Table 71. Deep Genomics Artificial Intelligence in Drug Discovery Product and Solutions
Table 72. Deep Genomics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Deep Genomics Recent Developments and Future Plans
Table 74. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 75. Cloud Pharmaceuticals Major Business
Table 76. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Product and Solutions
Table 77. Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 79. BenevolentAI Company Information, Head Office, and Major Competitors
Table 80. BenevolentAI Major Business
Table 81. BenevolentAI Artificial Intelligence in Drug Discovery Product and Solutions
Table 82. BenevolentAI Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. BenevolentAI Recent Developments and Future Plans
Table 84. Cyclica Company Information, Head Office, and Major Competitors
Table 85. Cyclica Major Business
Table 86. Cyclica Artificial Intelligence in Drug Discovery Product and Solutions
Table 87. Cyclica Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. Cyclica Recent Developments and Future Plans
Table 89. Verge Genomics Company Information, Head Office, and Major Competitors
Table 90. Verge Genomics Major Business
Table 91. Verge Genomics Artificial Intelligence in Drug Discovery Product and Solutions
Table 92. Verge Genomics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. Verge Genomics Recent Developments and Future Plans
Table 94. Valo Health Company Information, Head Office, and Major Competitors
Table 95. Valo Health Major Business
Table 96. Valo Health Artificial Intelligence in Drug Discovery Product and Solutions
Table 97. Valo Health Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Valo Health Recent Developments and Future Plans
Table 99. Envisagenics Company Information, Head Office, and Major Competitors
Table 100. Envisagenics Major Business
Table 101. Envisagenics Artificial Intelligence in Drug Discovery Product and Solutions
Table 102. Envisagenics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Envisagenics Recent Developments and Future Plans
Table 104. Euretos Company Information, Head Office, and Major Competitors
Table 105. Euretos Major Business
Table 106. Euretos Artificial Intelligence in Drug Discovery Product and Solutions
Table 107. Euretos Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Euretos Recent Developments and Future Plans
Table 109. BioAge Labs Company Information, Head Office, and Major Competitors
Table 110. BioAge Labs Major Business
Table 111. BioAge Labs Artificial Intelligence in Drug Discovery Product and Solutions
Table 112. BioAge Labs Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. BioAge Labs Recent Developments and Future Plans
Table 114. Iktos Company Information, Head Office, and Major Competitors
Table 115. Iktos Major Business
Table 116. Iktos Artificial Intelligence in Drug Discovery Product and Solutions
Table 117. Iktos Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 118. Iktos Recent Developments and Future Plans
Table 119. BioSymetrics Company Information, Head Office, and Major Competitors
Table 120. BioSymetrics Major Business
Table 121. BioSymetrics Artificial Intelligence in Drug Discovery Product and Solutions
Table 122. BioSymetrics Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 123. BioSymetrics Recent Developments and Future Plans
Table 124. Evaxion Biotech Company Information, Head Office, and Major Competitors
Table 125. Evaxion Biotech Major Business
Table 126. Evaxion Biotech Artificial Intelligence in Drug Discovery Product and Solutions
Table 127. Evaxion Biotech Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Evaxion Biotech Recent Developments and Future Plans
Table 129. Aria Pharmaceuticals, Inc Company Information, Head Office, and Major Competitors
Table 130. Aria Pharmaceuticals, Inc Major Business
Table 131. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Product and Solutions
Table 132. Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Aria Pharmaceuticals, Inc Recent Developments and Future Plans
Table 134. Global Artificial Intelligence in Drug Discovery Revenue (USD Million) by Players (2021-2026)
Table 135. Global Artificial Intelligence in Drug Discovery Revenue Share by Players (2021-2026)
Table 136. Breakdown of Artificial Intelligence in Drug Discovery by Company Type (Tier 1, Tier 2, and Tier 3)
Table 137. Market Position of Players in Artificial Intelligence in Drug Discovery, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 138. Head Office of Key Artificial Intelligence in Drug Discovery Players
Table 139. Artificial Intelligence in Drug Discovery Market: Company Product Type Footprint
Table 140. Artificial Intelligence in Drug Discovery Market: Company Product Application Footprint
Table 141. Artificial Intelligence in Drug Discovery New Market Entrants and Barriers to Market Entry
Table 142. Artificial Intelligence in Drug Discovery Mergers, Acquisition, Agreements, and Collaborations
Table 143. Global Artificial Intelligence in Drug Discovery Consumption Value (USD Million) by Type (2021-2026)
Table 144. Global Artificial Intelligence in Drug Discovery Consumption Value Share by Type (2021-2026)
Table 145. Global Artificial Intelligence in Drug Discovery Consumption Value Forecast by Type (2027-2032)
Table 146. Global Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026)
Table 147. Global Artificial Intelligence in Drug Discovery Consumption Value Forecast by Application (2027-2032)
Table 148. North America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 149. North America Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 150. North America Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 151. North America Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 152. North America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 153. North America Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 154. Europe Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 155. Europe Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 156. Europe Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 157. Europe Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 158. Europe Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 159. Europe Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 160. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 161. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 162. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 163. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 164. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Region (2021-2026) & (USD Million)
Table 165. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value by Region (2027-2032) & (USD Million)
Table 166. South America Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 167. South America Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 168. South America Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 169. South America Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 170. South America Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 171. South America Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 172. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Type (2021-2026) & (USD Million)
Table 173. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Type (2027-2032) & (USD Million)
Table 174. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Application (2021-2026) & (USD Million)
Table 175. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Application (2027-2032) & (USD Million)
Table 176. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Country (2021-2026) & (USD Million)
Table 177. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value by Country (2027-2032) & (USD Million)
Table 178. Global Key Players of Artificial Intelligence in Drug Discovery Upstream (Raw Materials)
Table 179. Global Artificial Intelligence in Drug Discovery Typical Customers
LIST OF FIGURES
Figure 1. Artificial Intelligence in Drug Discovery Picture
Figure 2. Global Artificial Intelligence in Drug Discovery Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type in 2025
Figure 4. Hardware
Figure 5. Software
Figure 6. Service
Figure 7. Global Artificial Intelligence in Drug Discovery Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application in 2025
Figure 9. Early Drug Discovery Picture
Figure 10. Preclinical Phase Picture
Figure 11. Clinical Phase Picture
Figure 12. Regulatory Approval Picture
Figure 13. Global Artificial Intelligence in Drug Discovery Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Artificial Intelligence in Drug Discovery Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Market Artificial Intelligence in Drug Discovery Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 16. Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Region (2021-2032)
Figure 17. Global Artificial Intelligence in Drug Discovery Consumption Value Market Share by Region in 2025
Figure 18. North America Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 20. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 21. South America Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 22. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Artificial Intelligence in Drug Discovery Revenue Share by Players in 2025
Figure 25. Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 26. Market Share of Artificial Intelligence in Drug Discovery by Player Revenue in 2025
Figure 27. Top 3 Artificial Intelligence in Drug Discovery Players Market Share in 2025
Figure 28. Top 6 Artificial Intelligence in Drug Discovery Players Market Share in 2025
Figure 29. Global Artificial Intelligence in Drug Discovery Consumption Value Share by Type (2021-2026)
Figure 30. Global Artificial Intelligence in Drug Discovery Market Share Forecast by Type (2027-2032)
Figure 31. Global Artificial Intelligence in Drug Discovery Consumption Value Share by Application (2021-2026)
Figure 32. Global Artificial Intelligence in Drug Discovery Market Share Forecast by Application (2027-2032)
Figure 33. North America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 34. North America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 35. North America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 40. Europe Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 41. Europe Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 42. Germany Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 43. France Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 44. United Kingdom Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 45. Russia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 46. Italy Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 48. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 49. Asia-Pacific Artificial Intelligence in Drug Discovery Consumption Value Market Share by Region (2021-2032)
Figure 50. China Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 51. Japan Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 52. South Korea Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 53. India Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 54. Southeast Asia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 55. Australia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 56. South America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 57. South America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 58. South America Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 59. Brazil Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 60. Argentina Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 61. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value Market Share by Type (2021-2032)
Figure 62. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value Market Share by Application (2021-2032)
Figure 63. Middle East & Africa Artificial Intelligence in Drug Discovery Consumption Value Market Share by Country (2021-2032)
Figure 64. Turkey Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 65. Saudi Arabia Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 66. UAE Artificial Intelligence in Drug Discovery Consumption Value (2021-2032) & (USD Million)
Figure 67. Artificial Intelligence in Drug Discovery Market Drivers
Figure 68. Artificial Intelligence in Drug Discovery Market Restraints
Figure 69. Artificial Intelligence in Drug Discovery Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Artificial Intelligence in Drug Discovery Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
